论文部分内容阅读
TF 是近10年发展起来的一种新的免疫促进剂,应用TF治疗是近代临床最新的一种免疫重建措施。它能从周围血、脾脏,摘除的扁桃体制备非特异性的TF,也能从患过白色念珠菌、球孢子菌病或对结素试验呈强阳性的人作供体,制备特异的TF,由于能提高细胞免疫功能,而抵制细胞内细菌、真菌、病毒感染的作用,故在肺部疾病中,对用抗痨药无效的重症肺结核,用二性霉素乙治疗无效的球孢子菌病,频繁感染的支气管哮喘等患者,分别在抗痨、抗真菌、抗细菌感染的同时,加用TF治疗,都取得了较好的效果。副作用少见。它的作用机理、免疫活性测定的方法,化学本质及临床应用尚存在大量的问题,有待今后解决。在肺部疾病中的应用,病例不多,资料较少,但从已取得的效果来看,这一疗法仍值得在免疫观测监护下,进一步应用。
TF is a new immunostimulant developed in recent 10 years. The application of TF therapy is the latest clinically clinically clinically new immune reconstitution measure. It produces nonspecific TFs from peripheral blood, spleen, and excercised tonsils. It also produces specific TFs from donors who have had Candida albicans, Coccidioidomycosis, or are strongly positive for the Knot test, Can improve cellular immune function, and to resist the role of bacteria, fungi, viral infection in the cell, so in lung disease, the use of anti-tuberculosis treatment of severe pulmonary tuberculosis, amphotericin B treatment of invalid coccidiosis, Frequent infections such as bronchial asthma and other patients, respectively, anti-痨, anti-fungal, anti-bacterial infections at the same time, plus TF treatment, have achieved good results. Rare side effects. Its mechanism of action, immunoassay method, chemical nature and clinical application are still a large number of problems to be solved in the future. The application of lung disease, few cases, less information, but the results have been achieved, the therapy is still worth under the supervision of the immune observation, further application.